Dipan Das, MD
Surgery of the Hand · Katy, TXNPI 1730261819
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $660 of the $772 with a category attached, or 85.6%. 11 manufacturers reported payments, led by Axogen at 58.7% of the total. 2025 is the largest year on record at $341, 6.9 times the $49 reported in 2019. That places this record below the midpoint for surgery of the hand clinicians in TX, where the typical reported total is $2,480.
Across 22 payments — averaging $35.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Axogen$453
- Endo Pharmaceuticals Inc.$90
- KCI USA, Inc.$41
- Johnson & Johnson$36
- Integra Lifesciences Corporation$30
- Anika Therapeutics, Inc.$28
- plus $93 from 5 others
What the payments were for
- Travel & lodging$9612%
- Food & beverage$66086%
- Education$152%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Axogen | 7 | $453 |
| Endo Pharmaceuticals Inc. | 6 | $90 |
| KCI USA, Inc. | 1 | $41 |
| Johnson & Johnson | 1 | $36 |
| Integra Lifesciences Corporation | 1 | $30 |
| Anika Therapeutics, Inc. | 1 | $28 |
| Biotissue Holdings Inc. | 1 | $21 |
| Medtronic | 1 | $20 |
| Endo USA, Inc. | 1 | $20 |
| Pacira Pharmaceuticals Incorporated | 1 | $18 |
| Trimed, Inc. | 1 | $15 |
How this compares
$772 in reported general payments places this provider in the 20th percentile of 68 surgery of the hand providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Acetaminophen-CodeineAcetaminophen With Codeine | 28 | $84 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 11 | $81 |
Paid to pharmacies, not to this prescriber.
Other surgery of the hand in Katy
- Desirae McKeeLubbock$59K
- Stuart HilliardDenton$21K
- Harrison KayAustin$19K
- Suresh KoneruSan Antonio$17K
- Dustin RayDallas$15K
- Laurence WeiderDallas$13K
- Andrew ZhangDallas$11K
- James HovisArlington$11K
- James LinSpring$10K
- Michael JonesSan Antonio$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.